Summary
Pfizer Inc. (PFE) filed a Form 8-K on February 28, 2017, to report on the pricing of a significant public offering of debt. The company priced an offering of $1,065,000,000 aggregate principal amount of 4.20% Notes due 2047. This offering was made under the company's existing shelf registration statement filed in March 2015. The primary purpose of this filing is to provide investors with transparency regarding this capital-raising activity and the associated agreements.
Key Highlights
- 1Pfizer priced a public offering of $1.065 billion in aggregate principal amount of 4.20% Notes due 2047 on February 24, 2017.
- 2The debt offering was conducted under Pfizer's shelf registration statement filed on March 2, 2015.
- 3The offering was managed by BNP Paribas, Taipei Branch and Deutsche Bank AG, Taipei Branch.
- 4The filing includes the Subscription Agreement dated February 24, 2017, as an exhibit.
- 5A press release related to the offering, dated February 24, 2017, is also filed as an exhibit.